Acquisition of Fusion completed - AstraZeneca
WEBJun 4, 2024 · AstraZeneca today announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).
AstraZeneca to acquire Fusion to accelerate the development of …
WEBMar 19, 2024 · AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).
AstraZeneca Pharma gets nod to sell immunotherapy drug …
WEB17 hours ago · AstraZeneca Pharma’s stock surged 12.6% on Tuesday to hit a 52-week high of ₹7,595.00 after the company received an approval from the Central Drugs Standard Control Organisation to import and distribute Durvalumab (Imfinzi). The approval has been received for Durvalumab infusion in two dosages—120 mg/2.4 mL and 500 mg/10 mL.
Fusion Pharmaceuticals to be Acquired by AstraZeneca, …
WEBMar 19, 2024 · Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, today announced the Company has...
AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma …
WEBMar 19, 2024 · The deal is AstraZeneca’s second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to shore up its rare disease portfolio. The drugmaker will pay $21 per Fusion share ...
AstraZeneca leaps after smashing first-quarter forecasts
WEBApril 25 (Reuters) - AstraZeneca (AZN.L) sailed past market expectations for quarterly revenue and profit on Thursday, boosted by demand for its blockbuster drugs and steady sales from partnered...
AstraZeneca bets on next-generation cancer therapy with $2 bln …
WEBMar 19, 2024 · AstraZeneca said on Tuesday it will buy Canadian drug developer Fusion Pharmaceuticals Inc for $2 billion in cash as the Anglo-Swedish drugmaker bets on next-generation cancer treatments.
AstraZeneca CEO believes the company can almost double …
WEBJun 4, 2024 · AstraZeneca announced in late May that it had set a goal to raise revenue to $80 billion by the end of the decade, up from $45.8 billion in 2023. The pharmaceutical giant also plans to release...
A decade after Pfizer, AstraZeneca needs to find its growth again
WEBApr 1, 2024 · Today, AstraZeneca has 13 blockbusters, led by diabetes treatment Farxiga and oncology drug Tagrisso. Patents on the former will start to expire in the next few years.
AstraZeneca ties up with AI biologics company to develop cancer …
WEBDec 3, 2023 · AstraZeneca has signed a deal worth up to $247mn with Absci Corporation of the US to design an antibody to fight cancer, the latest tie-up in fast-expanding efforts to use artificial...
- Some results have been removed
Skip to content